Table 2.
Treatment | Observed species | Shannon | Simpson | Chao1 | ACE |
---|---|---|---|---|---|
CTL | 413.14 ± 34.99a | 3.36 ± 0.26a | 0.81 ± 0.03 | 497.33 ± 38.64a | 513.47 ± 39.84a |
CP | 1748.43 ± 44.53c | 4.97 ± 0.23b | 0.80 ± 0.04 | 2168.13 ± 90.76c | 2255.53 ± 76.13c |
ARGCP | 816.86 ± 58.06b | 3.46 ± 0.20a | 0.77 ± 0.03 | 1098.40 ± 78.02b | 1172.03 ± 78.57b |
P-value | < 0.001 | < 0.001 | 0.677 | < 0.001 | < 0.001 |
Values within a column followed by different superscript letters differ significantly (P < 0.05). CTL, non-challenge control; CP, C. perfringens-challenged group; ARGCP, C. perfringens-challenged group fed diet supplemented with 0.3% l-arginine. VH, villus height; CD, crypt depth; VCR, the ratio of VH:CD. Data are shown as the mean ± standard error.